YOKNEAM, Israel--(BUSINESS WIRE)--EndoCross, Ltd., received CE Mark approval for the ENABLER-C Coronary Catheter System. The ENABLER-C features a unique controlled guidewire advancement technology currently available in the CE Marked ENABLER-P Peripheral Catheter Systems. The CE Mark of the ENABLER-C Coronary Catheter System follows the successful first-in-man study of the ENABLER-C that took place at the Institut Cardiovasculaire Paris-Sud.
“EndoCross has developed a unique chronic occlusion crossing device that can facilitate penetration and crossing of complex occlusions with standard off-the-shelf wires. The device allows for effective and controlled luminal crossing.” said Dr. Maurice Buchbinder, M.D., Chief Medical Officer of EndoCross.
Hey, check out all the research scientist jobs. Post your resume today!
